Answers are grounded in this paper and cite their sources.
Our results suggest that topical insulin, due to its good safety profile, availability, and affordability, could be a good therapeutic alternative for persistent epithelial defects.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: